trastuzumab

trastuzumab

美 　英

• 網絡曲妥珠單抗；曲妥單抗；賀癌平

例句

They also found that this synergy occurred with trastuzumab and either paclitaxel or vincristine.

他們發現這種協同作用也發生在脂質體和長春新堿或紫杉醇。

These include the introduction of aromatase inhibitors, new chemotherapy agents, and the novel antibody trastuzumab.

其中包括芳香酶抑制劑，新的化療藥物，以及實施新的抗體曲妥。

Pertuzumab can even disrupt certain types of HER2 activation in tumor cells that have become resistant to trastuzumab.

對已具有賀癌平抗藥性的腫瘤細胞，pertuzumab甚至可抑制HER2的活化。

CASE: A 41-year-old woman with infiltrating ductal carcinoma of the breast was undergoing chemotherapy with paclitaxel and trastuzumab.

案例：41歲女子與浸潤性導管癌乳腺是接受化療紫杉醇和曲妥。

Trastuzumab is a monoclonal antibody that directly targets part of the HER2 tyrosine kinase receptor.

曲妥單抗是一種直接針對HER2酪氨酸激酶受體的單抗。

In early use, trastuzumab is approved for use following standard (adjuvant) chemotherapy.

在早期使用中，曲妥珠單抗可作為以后的標準化化療藥物。

Conversely, in the absence of HRG, trastuzumab promotes this effect in cells producing low amounts of the HER-2 protein.

相反，在缺乏HRG時，對于那些生產低水平數量HER-2蛋白細胞來說，脂質體促進了這個影響。

Similarly, because her tumor is HER-2 negative, she is unlikely to benefit from administration of trastuzumab.

類似地，因為她的HER-2受體陰性，她不大可能從曲妥珠單抗治療中獲益。